$0.10 EPS Expected for IntriCon Co. (IIN) This Quarter

Brokerages expect IntriCon Co. (NASDAQ:IIN) to announce $0.10 earnings per share (EPS) for the current fiscal quarter, according to Zacks Investment Research. Two analysts have provided estimates for IntriCon’s earnings. The lowest EPS estimate is $0.09 and the highest is $0.10. IntriCon also reported earnings per share of $0.10 in the same quarter last year. The company is expected to report its next quarterly earnings report on Monday, May 6th.

According to Zacks, analysts expect that IntriCon will report full year earnings of $0.66 per share for the current fiscal year, with EPS estimates ranging from $0.62 to $0.70. For the next year, analysts forecast that the company will report earnings of $1.25 per share, with EPS estimates ranging from $1.00 to $1.65. Zacks Investment Research’s EPS calculations are a mean average based on a survey of research analysts that cover IntriCon.

IntriCon (NASDAQ:IIN) last issued its earnings results on Tuesday, February 19th. The technology company reported $0.09 earnings per share for the quarter, missing the consensus estimate of $0.16 by ($0.07). The firm had revenue of $30.81 million during the quarter, compared to the consensus estimate of $30.30 million. IntriCon had a return on equity of 9.63% and a net margin of 4.76%.

Several analysts have commented on IIN shares. ValuEngine upgraded shares of IntriCon from a “hold” rating to a “buy” rating in a research note on Saturday. Dougherty & Co upgraded shares of IntriCon from a “neutral” rating to a “buy” rating and set a $44.00 target price on the stock in a research report on Thursday, January 3rd. Zacks Investment Research cut shares of IntriCon from a “buy” rating to a “hold” rating in a research report on Friday, January 4th. BidaskClub cut shares of IntriCon from a “buy” rating to a “hold” rating in a research report on Wednesday, December 12th. Finally, Stifel Nicolaus decreased their target price on shares of IntriCon from $70.00 to $45.00 and set a “buy” rating on the stock in a research report on Friday, January 4th. Two research analysts have rated the stock with a hold rating and four have given a buy rating to the stock. The company has an average rating of “Buy” and an average price target of $50.25.

IIN stock traded up $2.37 during mid-day trading on Friday, hitting $25.08. The company had a trading volume of 293,507 shares, compared to its average volume of 172,099. The stock has a market cap of $218.45 million, a P/E ratio of 39.19, a PEG ratio of 2.85 and a beta of 1.23. IntriCon has a 12-month low of $18.85 and a 12-month high of $76.80.

In other news, VP Greg Gruenhagen sold 1,500 shares of the company’s stock in a transaction dated Thursday, January 3rd. The shares were sold at an average price of $25.37, for a total transaction of $38,055.00. Following the sale, the vice president now directly owns 2,455 shares in the company, valued at approximately $62,283.35. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders have sold a total of 4,500 shares of company stock worth $115,365 over the last 90 days. Corporate insiders own 11.50% of the company’s stock.

Large investors have recently modified their holdings of the stock. MetLife Investment Advisors LLC bought a new position in IntriCon during the 3rd quarter valued at about $295,000. Shell Asset Management Co. bought a new position in IntriCon during the 3rd quarter valued at about $310,000. Sun Life Financial INC bought a new position in IntriCon during the 4th quarter valued at about $155,000. Russell Investments Group Ltd. bought a new position in IntriCon during the 3rd quarter valued at about $348,000. Finally, Alliancebernstein L.P. bought a new position in IntriCon during the 3rd quarter valued at about $393,000. Institutional investors own 64.16% of the company’s stock.

About IntriCon

IntriCon Corporation, together with its subsidiaries, designs, develops, engineers, manufactures, and distributes body-worn devices in the United States, Europe, Asia, and internationally. The company operates in two segments, Body Worn Devices and Hearing Health Direct-To-Consumer. It offers micro-miniature products, microelectronics; micro-mechanical assemblies; high-precision injection-molded plastic components; and assemblies and software solutions for medical bio-telemetry devices, hearing healthcare, and professional audio communication devices markets.

See Also: What is a front-end load?

Get a free copy of the Zacks research report on IntriCon (IIN)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for IntriCon (NASDAQ:IIN)

Receive News & Ratings for IntriCon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IntriCon and related companies with MarketBeat.com's FREE daily email newsletter.